CD5+ B cells from individuals with systemic lupus erythematosus express granzyme B

European Journal of Immunology

Volumn 40, Issue 7, 2010, Pages 2060-2069

  Hagn, Magdalena ^a   Ebel, Verena ^a   Sontheimer, Kai ^a   Schwesinger, Elisabeth ^a   Lunov, Oleg ^a   Beyer, Thamara ^a   Fabricius, Dorit ^a   Barth, Thomas F E ^a   Viardot, Andreas ^a   Stilgenbauer, Stephan ^a   Hepp, Julia ^a   Scharffetter Kochanek, Karin ^a   Simmet, Thomas ^a   Jahrsdörfer, Bernd ^a  

^a UNIVERSITY OF ULM   (Germany)

Author keywords

Apoptosis; Autoimmunity; B cells; BCR; Immune regulation

Indexed keywords

CD5 ANTIGEN; GRANZYME B; INTERLEUKIN 21; GRANZYME; INTERLEUKIN 21 RECEPTOR; INTERLEUKIN DERIVATIVE; LYMPHOCYTE ANTIGEN RECEPTOR;

ADULT; APOPTOSIS; ARTICLE; AUTOIMMUNITY; B LYMPHOCYTE; BLOOD SAMPLING; CELL ISOLATION; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; IMMUNOREGULATION; IN VITRO STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SYSTEMIC LUPUS ERYTHEMATOSUS; UMBILICAL CORD BLOOD FLOW; ADOLESCENT; AGED; BIOSYNTHESIS; BLOOD; CELL PROLIFERATION; CELL SURVIVAL; FEMALE; GENETICS; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; METABOLISM; MIDDLE AGED; PATHOLOGY; SIGNAL TRANSDUCTION;

ADOLESCENT; ADULT; AGED; ANTIGENS, CD5; B-LYMPHOCYTES; CELL PROLIFERATION; CELL SURVIVAL; FEMALE; GRANZYMES; HUMANS; IMMUNE TOLERANCE; INTERLEUKINS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; RECEPTOR CROSS-TALK; RECEPTORS, ANTIGEN, B-CELL; RECEPTORS, INTERLEUKIN-21;

EID: 77954122576     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.200940113     Document Type: Article

References (51)

1. Berland, R. and Wortis, H. H., Origins and functions of B-1 cells with notes on the role of CD5. Annu. Rev. Immunol. 2002. 20: 253-300.
2. Duan, B. and Morel, L., Role of B-1a cells in autoimmunity. Autoimmun. Rev. 2006. 5: 403-408.
3. Renaudineau, Y., Pers, J. O., Bendaoud, B., Jamin, C. and Youinou, P., Dysfunctional B cells in systemic lupus erythematosus. Autoimmun. Rev. 2004. 3: 516-523.
4. Hayakawa, K. and Hardy, R. R., Normal, autoimmune, and malignant CD5 + B cells: the Ly-1 B lineage? Annu. Rev. Immunol. 1988. 6: 197-218.
5. Casali, P., Burastero, S. E., Nakamura, M., Inghirami, G. and Notkins, A. L., Human lymphocytes making rheumatoid factor and antibody to ssDNA belong to Leu-1+ B-cell subset. Science 1987. 236: 77-81. (Pubitemid 17056816)
6. Youinou, P. and Renaudineau, Y., The paradox of CD5-expressing B cells in systemic lupus erythematosus. Autoimmun. Rev. 2007. 7: 149-154.
7. Yanaba, K., Bouaziz, J. D., Haas, K. M., Poe, J. C., Fujimoto, M. and Tedder, T. F., A regulatory B cell subset with a unique CD1dhiCD5+ phenotype controls T cell-dependent inflammatory responses. Immunity 2008. 28: 639-650.
8. Dass, S., Vital, E. M. and Emery, P., Development of psoriasis after B cell depletion with rituximab. Arthritis Rheum. 2007. 56: 2715-2718.
9. Parrish-Novak, J., Dillon, S. R., Nelson, A., Hammond, A., Sprecher, C., Gross, J. A., Johnston, J. et al., Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function. Nature 2000. 408: 57-63.
10. Spolski, R. and Leonard, W. J., Interleukin-21: basic biology and implications for cancer and autoimmunity. Annu. Rev. Immunol. 2008. 26: 57-79.
11. Spolski, R. and Leonard, W. J., The Yin and Yang of interleukin-21 in allergy, autoimmunity and cancer. Curr. Opin. Immunol. 2008. 20: 295-301.
12. Habib, T., Nelson, A. and Kaushansky, K., IL-21: a novel IL-2-family lymphokine that modulates B, T, and natural killer cell responses. J. Allergy Clin. Immunol. 2003. 112: 1033-1045.
13. Ettinger, R., Kuchen, S. and Lipsky, P. E., The role of IL-21 in regulating B-cell function in health and disease. Immunol. Rev. 2008. 223: 60-86.
14. Ettinger, R., Kuchen, S. and Lipsky, P. E., Interleukin 21 as a target of intervention in autoimmune disease. Ann. Rheum. Dis. 2008. 67: iii83-iii86.
15. Hagn, M., Schwesinger, E., Ebel, V., Sontheimer, K., Maier, J., Beyer, T., Syrovets, T. et al., Human B cells secrete granzyme B when recognizing viral antigens in the context of the acute phase cytokine IL-21. J. Immunol. 2009 183: 1838-1845.
16. Lieberman, J., The ABCs of granule-mediated cytotoxicity: new weapons in the arsenal. Nat. Rev. Immunol. 2003. 3: 361-370.
17. Jahrsdörfer, B., Vollmer, A., Blackwell, S. E., Maier, J., Sontheimer, K., Beyer, T., Mandel, B. et al., Granzyme B produced by human plasmacytoid dendritic cells suppresses T-cell expansion. Blood 2010. 115: 1156-1165.
18. Jahrsdörfer, B., Blackwell, S. E., Wooldridge, J. E., Huang, J., Andreski, M. W., Jacobus, L. S., Taylor, C. M. and Weiner, G. J., B-chronic lymphocytic leukemia cells and other B cells can produce granzyme B and gain cytotoxic potential after interleukin-21-based activation. Blood 2006. 108: 2712-2719.
19. Tschopp, C. M., Spiegl, N., Didichenko, S., Lutmann, W., Julius, P., Virchow, J. C., Hack, C. E. and Dahinden, C. A., Granzyme B, a novel mediator of allergic inflammation: its induction and release in blood basophils and human asthma. Blood 2006. 108: 2290-2299.
20. Strik, M. C., de Koning, P. J., Kleijmeer, M. J., Bladergroen, B. A., Wolbink, A. M., Griffith, J. M. et al., Human mast cells produce and release the cytotoxic lymphocyte associated protease granzyme B upon activation. Mol. Immunol. 2007. 44: 3462-3472.
21. Berthou, C., Marolleau, J. P., Lafaurie, C., Soulie, A., Dal Cortivo, L., Bourge, J. F., Benbunan, M. and Sasportes, M., Granzyme B and perforin lytic proteins are expressed in CD34+ peripheral blood progenitor cells mobilized by chemotherapy and granulocyte colony-stimulating factor. Blood 1995. 86: 3500-3506.
22. Devadas, S., Das, J., Liu, C., Zhang, L., Roberts, A. I., Pan, Z., Moore, P. A. et al., Granzyme B is critical for T cell receptor-induced cell death of type 2 helper T cells. Immunity 2006. 25: 237-247.
23. Gondek, D. C., Lu, L. F., Quezada, S. A., Sakaguchi, S. and Noelle, R. J., Cutting edge: contact-mediated suppression by CD4+CD25+ regulatory cells involves a granzyme B-dependent, perforin-independent mechanism. J. Immunol. 2005. 174: 1783-1786.
24. Wieckowski, E., Wang, G. Q., Gastman, B. R., Goldstein, L. A. and Rabinowich, H., Granzyme B-mediated degradation of T-cell receptor zeta chain. Cancer Res. 2002. 62: 4884-4889. (Pubitemid 34984408)
25. Casciola-Rosen, L., Andrade, F., Ulanet, D., Wong, W. B. and Rosen, A., Cleavage by granzyme B is strongly predictive of autoantigen status: implications for initiation of autoimmunity. J. Exp. Med. 1999. 190: 815-826.
26. Rosen, A. and Casciola-Rosen, L., Autoantigens as substrates for apoptotic proteases: implications for the pathogenesis of systemic autoimmune disease. Cell Death Differ. 1999. 6: 6-12. (Pubitemid 29051849)
27. Metkar, S. S., Menaa, C., Pardo, J.,Wang, B.,Wallich, R., Freudenberg, M., Kim, S. et al., Human and mouse granzyme A induce a proinflammatory cytokine response. Immunity 2008. 29: 720-733.
28. Darrah, E. and Rosen, A., Granzyme B cleavage of autoantigens in autoimmunity. Cell Death Differ. 2010. 17: 624-632.
29. Casciola-Rosen, L., Miagkov, A., Nagaraju, K., Askin, F., Jacobson, L., Rosen, A. and Drachman, D. B., Granzyme B: evidence for a role in the origin of myasthenia gravis. J. Neuroimmunol. 2008. 201-202: 33-40.
30. Froelich, C. J., Zhang, X., Turbov, J., Hudig, D., Winkler, U. and Hanna, W. L., Human granzyme B degrades aggrecan proteoglycan in matrix synthesized by chondrocytes. J. Immunol. 1993. 151: 7161-7171. (Pubitemid 24001090)
31. Buzza, M. S. and Bird, P. I., Extracellular granzymes: current perspectives. Biol. Chem. 2006. 387: 827-837.
32. Romero, V. and Andrade, F., Non-apoptotic functions of granzymes. Tissue Antigens 2008. 71: 409-416.
33. Holm, C., Nyvold, C. G., Paludan, S. R., Thomsen, A. R. and Hokland, M., Interleukin-21 mRNA expression during virus infections. Cytokine 2006. 33: 41-45.
34. Spaeny-Dekking, E. H., Hanna, W. L., Wolbink, A. M., Wever, P. C., Kummer, A. J., Swaak, A. J. et al., Extracellular granzymes A and B in humans: detection of native species during CTL responses in vitro and in vivo. J. Immunol. 1998. 160: 3610-3616.
35. Bubier, J. A., Bennett, S. M., Sproule, T. J., Lyons, B. L., Olland, S., Young, D. A. and Roopenian, D. C., Treatment of BXSB-Yaa mice with IL-21R-Fc fusion protein minimally attenuates systemic lupus erythematosus. Ann. NY Acad. Sci. 2007. 1110: 590-601.
36. Sawalha, A. H., Kaufman, K. M., Kelly, J. A., Adler, A. J., Aberle, T., Kilpatrick, J., Wakeland, E. K. et al., Genetic association of interleukin-21 polymorphisms with systemic lupus erythematosus. Ann. Rheum. Dis. 2008. 67: 458-461.
37. Mitoma, H., Horiuchi, T., Kimoto, Y., Tsukamoto, H., Uchino, A., Tamimoto, Y., Miyagi, Y. and Harada, M., Decreased expression of interleukin-21 receptor on peripheral B lymphocytes in systemic lupus erythematosus. Int. J. Mol. Med. 2005. 16: 609-615.
38. Graham, K. L., Thibault, D. L., Steinman, J. B., Okeke, L., Kao, P. N. and Utz, P. J., Granzyme B is dispensable for immunologic tolerance to self in a murine model of systemic lupus erythematosus. Arthritis Rheum. 2005. 52: 1684-1693.
39. Sims, G. P., Ettinger, R., Shirota, Y., Yarboro, C. H., Illei, G. G. and Lipsky, P. E., Identification and characterization of circulating human transitional B cells. Blood 2005. 105: 4390-4398.
40. Ida, H., Nakashima, T., Kedersha, N. L., Yamasaki, S., Huang, M., Izumi, Y.,Miyashita, T. et al., Granzyme B leakage-induced cell death: a new type of activation-induced natural killer cell death. Eur. J. Immunol. 2003. 33: 3284-3292.
41. Ettinger, R., Sims, G. P., Robbins, R., Withers, D., Fischer, R. T., Grammer, A. C., Kuchen, S. and Lipsky, P. E., IL-21 and BAFF/BLyS synergize in stimulating plasma cell differentiation from a unique population of human splenic memory B cells. J. Immunol. 2007. 178: 2872-2882.
42. Vignali, D. A., Collison, L. W. and Workman, C. J., How regulatory T cells work. Nat. Rev. Immunol. 2008. 8: 523-532.
43. Van Damme, P., Maurer-Stroh, S., Plasman, K., Van Durme, J., Colaert, N., Timmerman, E., Debock, P. J. et al., Analysis of protein processing by N-terminal proteomics reveals novel species-specific substrate determinants of granzyme B orthologs. Mol. Cell. Proteomics 2009 8: 258-272.
44. Elsaesser, H., Sauer, K. and Brooks, D. G., IL-21 is required to control chronic viral infection. Science 2009. 324: 1569-1572.
45. Johnson, L. D. and Jameson, S. C., Immunology. A chronic need for IL-21. Science 2009. 324: 1525-1526.
46. Yi, J. S., Du, M. and Zajac, A. J., A vital role for interleukin-21 in the control of a chronic viral infection. Science 2009. 324: 1572-1576.
47. Bubier, J. A., Sproule, T. J., Foreman, O., Spolski, R., Shaffer, D. J., Morse, H. C., III, Leonard, W. J. and Roopenian, D. C., A critical role for IL-21 receptor signaling in the pathogenesis of systemic lupus erythematosus in BXSB-Yaa mice. Proc. Natl. Acad. Sci. USA 2009. 106: 1518-1523.
48. Herber, D., Brown, T. P., Liang, S., Young, D. A., Collins, M. and Dunussi-Joannopoulos, K., IL-21 has a pathogenic role in a lupus-prone mouse model and its blockade with IL-21R.Fc reduces disease progression. J. Immunol. 2007. 178: 3822-3830. (Pubitemid 46417651)
49. Good, K. L., Bryant, V. L. and Tangye, S. G., Kinetics of human B cell behavior and amplification of proliferative responses following stimulation with IL-21. J. Immunol. 2006. 177: 5236-5247.
50. Jahrsdörfer, B., Wooldridge, J. E., Blackwell, S. E., Taylor, C. M., Griffith, T. S., Link, B. K. and Weiner, G. J., Immunostimulatory oligodeoxynucleotides induce apoptosis of B cell chronic lymphocytic leukemia cells. J. Leukoc. Biol. 2005. 77: 378-387.
51. Hagn, M., Schwesinger, E., Ebel, V., Sontheimer, K., Maier, J., Beyer, T., Syrovets, T. et al., Human B cells secrete granzyme B when recognizing viral antigens in the context of the acute phase cytokine IL-21. J. Immunol. 2009. 183: 1838-1845.